These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33326104)

  • 21. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.
    Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F
    Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Migration and Invasion in Ewing Sarcoma.
    Cidre-Aranaz F
    Methods Mol Biol; 2021; 2226():167-179. PubMed ID: 33326101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral breast metastases from ewing sarcoma of the femur.
    Astudillo L; Lacroix-Triki M; Ferron G; Rolland F; Maisongrosse V; Chevreau C
    Am J Clin Oncol; 2005 Feb; 28(1):102-3. PubMed ID: 15685043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies.
    Hense HW; Ahrens S; Paulussen M; Lehnert M; Jürgens H
    Ann Oncol; 1999 Sep; 10(9):1073-7. PubMed ID: 10572605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
    Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
    Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Ewing Sarcoma Presenting With Cardiac Metastasis.
    Murad R; Bakkar R; Sukkar R; Mahmoud F; Al-Dairy A
    World J Pediatr Congenit Heart Surg; 2019 Sep; 10(5):632-634. PubMed ID: 31496409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.
    Worch J; Ranft A; DuBois SG; Paulussen M; Juergens H; Dirksen U
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27251. PubMed ID: 29856530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
    Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
    J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-directed Implantation Using Ultrasound Visualization for Development of Biologically Relevant Metastatic Tumor Xenografts.
    VAN Noord RA; Thomas T; Krook M; Chukkapalli S; Hoenerhoff MJ; Dillman JR; Lawlor ER; Opipari VP; Newman EA
    In Vivo; 2017; 31(5):779-791. PubMed ID: 28882943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of Ewing sarcoma in children and adolescents with Ewing sarcoma: a five-year survival from a single institution.
    Zawitkowska-Klaczyńska J; Drabko K; Katski K; Wozniak M; Kowalczyk JR
    Pediatr Hematol Oncol; 2004; 21(7):627-33. PubMed ID: 15626019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.
    Twardziok M; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
    PLoS One; 2016; 11(9):e0159749. PubMed ID: 27589063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma.
    Cidre-Aranaz F; Li J; Hölting TLB; Orth MF; Imle R; Kutschmann S; Ammirati G; Ceranski K; Carreño-Gonzalez MJ; Kasan M; Marchetto A; Funk CM; Bestvater F; Bersini S; Arrigoni C; Moretti M; Thiel U; Baumhoer D; Sahm F; Pfister SM; Hartmann W; Dirksen U; Romero-Pérez L; Banito A; Ohmura S; Musa J; Kirchner T; Knott MML; Grünewald TGP
    Mol Cancer; 2022 Jan; 21(1):1. PubMed ID: 34980141
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishment and Characterisation of Metastatic Extraskeletal Ewing Sarcoma Mouse Models.
    Cerra C; Harris MA; Hawkins CJ
    In Vivo; 2021; 35(6):3097-3106. PubMed ID: 34697140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenograft Model.
    Giner F; López-Guerrero JA; Fernández-Serra A; Machado I; Mayordomo-Aranda E; Peydró-Olaya A; Llombart-Bosch A
    Pediatr Dev Pathol; 2019; 22(1):30-39. PubMed ID: 29895220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
    Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
    Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.
    Hatano M; Matsumoto Y; Fukushi J; Matsunobu T; Endo M; Okada S; Iura K; Kamura S; Fujiwara T; Iida K; Fujiwara Y; Nabeshima A; Yokoyama N; Fukushima S; Oda Y; Iwamoto Y
    Clin Exp Metastasis; 2015 Aug; 32(6):579-91. PubMed ID: 26092671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
    Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
    Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Kiyuna T; Kawaguchi K; Higuchi T; Oshiro H; Zhang Z; Wangsiricharoen S; Razmjooei S; Li Y; Nelson SD; Murakami T; Hiroshima Y; Matsuyama R; Bouvet M; Chawla SP; Singh SR; Endo I; Hoffman RM
    Cancer Chemother Pharmacol; 2019 May; 83(5):809-815. PubMed ID: 30758647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.
    Leuchte K; Altvater B; Hoffschlag S; Potratz J; Meltzer J; Clemens D; Luecke A; Hardes J; Dirksen U; Juergens H; Kailayangiri S; Rossig C
    Oncol Rep; 2014 Aug; 32(2):845-52. PubMed ID: 24927333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.